AzurRx BioPharma, Inc.

AZRX · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$2,517$4$59$163
Short-Term Investments$0$0$0$0
Receivables$37$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$85,144$83,314$83,404$83,315
Total Curr. Assets$87,699$83,319$83,463$83,479
Property Plant & Equip (Net)$28$0$0$127
Goodwill$25,796$1,684$1,684$1,684
Intangibles$0$0$0$0
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$21,848$56$56$120
Total NC Assets$47,672$1,740$1,740$1,931
Other Assets$0$0$0$0
Total Assets$135,370$85,059$85,204$85,410
Liabilities
Payables$4,973$3,298$2,850$2,959
Short-Term Debt$836$836$836$82
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$27,707$25,542$25,055$24,505
Total Curr. Liab.$33,516$29,676$28,740$27,546
LT Debt$0$0$0$59
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$12,292$0$0$0
Total NC Liab.$12,292$0$0$59
Other Liabilities$0$0$0$0
Cap. Leases$0$0$0$0
Total Liabilities$45,808$29,676$28,740$27,605
Equity
Pref Stock$61,681$61,681$61,681$61,681
Common Stock$0$0$0$0
Retained Earnings-$205,799-$204,646-$203,648-$202,388
AOCI$0$0$0$0
Other Equity$233,679$198,347$198,430$198,511
Total Equity$27,881-$6,298-$5,218-$3,877
Supplemental Information
Minority Interest$5,287$0$0$0
Total Liab. & Tot. Equity$135,370$85,059$85,204$85,410
Net Debt-$1,682$831$776-$23